Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Disease, Chronic Obstructive | 25 | 2024 | 3253 | 3.470 |
Why?
|
Idiopathic Pulmonary Fibrosis | 4 | 2023 | 522 | 1.370 |
Why?
|
Lung Diseases, Interstitial | 6 | 2024 | 940 | 1.010 |
Why?
|
Genetic Predisposition to Disease | 12 | 2024 | 18068 | 0.680 |
Why?
|
Spirometry | 7 | 2024 | 929 | 0.660 |
Why?
|
Pulmonary Emphysema | 2 | 2024 | 689 | 0.640 |
Why?
|
Respiratory Tract Diseases | 1 | 2024 | 744 | 0.630 |
Why?
|
Genome-Wide Association Study | 9 | 2024 | 12801 | 0.580 |
Why?
|
Heparin | 3 | 2021 | 1636 | 0.570 |
Why?
|
Smoking | 6 | 2024 | 9094 | 0.530 |
Why?
|
Genetic Markers | 2 | 2022 | 2604 | 0.510 |
Why?
|
Vital Capacity | 6 | 2024 | 996 | 0.500 |
Why?
|
Multifactorial Inheritance | 4 | 2024 | 1423 | 0.480 |
Why?
|
Lung | 12 | 2023 | 10099 | 0.450 |
Why?
|
Mortality | 1 | 2024 | 2914 | 0.420 |
Why?
|
Disease Progression | 5 | 2024 | 13674 | 0.400 |
Why?
|
Forced Expiratory Volume | 5 | 2024 | 1831 | 0.390 |
Why?
|
Drug Repositioning | 2 | 2024 | 246 | 0.380 |
Why?
|
Respiratory Function Tests | 5 | 2023 | 1694 | 0.370 |
Why?
|
Asthma | 4 | 2023 | 6293 | 0.370 |
Why?
|
Venous Thromboembolism | 2 | 2021 | 1881 | 0.370 |
Why?
|
Arthritis, Rheumatoid | 5 | 2024 | 3780 | 0.360 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1321 | 0.360 |
Why?
|
Intensive Care Units | 2 | 2021 | 3800 | 0.340 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2024 | 16053 | 0.330 |
Why?
|
Mucin-5B | 3 | 2023 | 148 | 0.310 |
Why?
|
Hypertension, Pulmonary | 4 | 2021 | 1601 | 0.290 |
Why?
|
Risk Factors | 16 | 2024 | 74976 | 0.290 |
Why?
|
Pulmonary Embolism | 1 | 2020 | 2600 | 0.270 |
Why?
|
Phenotype | 8 | 2024 | 16731 | 0.270 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3118 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.250 |
Why?
|
Inflammation | 2 | 2023 | 10868 | 0.230 |
Why?
|
Antihypertensive Agents | 3 | 2020 | 2027 | 0.220 |
Why?
|
Humans | 55 | 2024 | 768970 | 0.220 |
Why?
|
Anticoagulants | 4 | 2021 | 4850 | 0.200 |
Why?
|
Risk Assessment | 3 | 2024 | 24333 | 0.200 |
Why?
|
Middle Aged | 21 | 2024 | 223737 | 0.190 |
Why?
|
Emphysema | 1 | 2024 | 236 | 0.190 |
Why?
|
Respiratory System Abnormalities | 1 | 2022 | 67 | 0.190 |
Why?
|
Pulmonary Artery | 2 | 2020 | 1945 | 0.190 |
Why?
|
alpha 1-Antitrypsin | 1 | 2022 | 169 | 0.180 |
Why?
|
Mitochondria, Liver | 1 | 2021 | 190 | 0.180 |
Why?
|
Acetyltransferases | 1 | 2021 | 231 | 0.180 |
Why?
|
Prothrombin Time | 1 | 2020 | 117 | 0.170 |
Why?
|
Partial Thromboplastin Time | 1 | 2020 | 204 | 0.170 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15661 | 0.160 |
Why?
|
Epoprostenol | 1 | 2020 | 246 | 0.160 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 412 | 0.160 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2021 | 141 | 0.160 |
Why?
|
Anti-Asthmatic Agents | 1 | 2023 | 577 | 0.150 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.150 |
Why?
|
Enoxaparin | 1 | 2020 | 391 | 0.150 |
Why?
|
Ferritins | 1 | 2020 | 600 | 0.140 |
Why?
|
Male | 23 | 2024 | 365203 | 0.140 |
Why?
|
Female | 25 | 2024 | 397515 | 0.140 |
Why?
|
Internationality | 1 | 2022 | 1008 | 0.140 |
Why?
|
Aged | 14 | 2024 | 171786 | 0.140 |
Why?
|
Fibrinogen | 1 | 2020 | 892 | 0.140 |
Why?
|
Cohort Studies | 4 | 2024 | 41808 | 0.130 |
Why?
|
Proteomics | 3 | 2024 | 3914 | 0.130 |
Why?
|
Sebaceous Glands | 1 | 2016 | 42 | 0.130 |
Why?
|
Models, Genetic | 2 | 2024 | 3449 | 0.130 |
Why?
|
Meta-Analysis as Topic | 1 | 2021 | 1364 | 0.130 |
Why?
|
Severity of Illness Index | 4 | 2022 | 15951 | 0.130 |
Why?
|
Odds Ratio | 3 | 2022 | 9684 | 0.120 |
Why?
|
Blood Coagulation | 1 | 2021 | 1161 | 0.120 |
Why?
|
Interleukin-10 | 1 | 2020 | 1183 | 0.120 |
Why?
|
Heterozygote | 1 | 2022 | 2798 | 0.120 |
Why?
|
Acetamides | 1 | 2016 | 260 | 0.120 |
Why?
|
Sarcoidosis | 1 | 2020 | 535 | 0.120 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15471 | 0.120 |
Why?
|
rho-Associated Kinases | 1 | 2016 | 285 | 0.110 |
Why?
|
Pandemics | 4 | 2022 | 8749 | 0.110 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1381 | 0.110 |
Why?
|
Cause of Death | 2 | 2024 | 3721 | 0.110 |
Why?
|
Drugs, Investigational | 1 | 2015 | 212 | 0.110 |
Why?
|
Gene Expression Regulation | 2 | 2022 | 11932 | 0.110 |
Why?
|
Amides | 1 | 2016 | 452 | 0.110 |
Why?
|
Propensity Score | 1 | 2021 | 1968 | 0.110 |
Why?
|
Gene Expression Profiling | 3 | 2024 | 9549 | 0.110 |
Why?
|
Hypersensitivity, Immediate | 1 | 2016 | 349 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 4 | 2024 | 20776 | 0.100 |
Why?
|
Adult | 14 | 2024 | 223851 | 0.100 |
Why?
|
Pyrazines | 1 | 2016 | 1206 | 0.090 |
Why?
|
Genotype | 2 | 2023 | 13048 | 0.090 |
Why?
|
Interleukin-6 | 1 | 2020 | 3232 | 0.090 |
Why?
|
Vitamin D Deficiency | 1 | 2020 | 1388 | 0.090 |
Why?
|
Genetic Variation | 2 | 2022 | 6611 | 0.090 |
Why?
|
Alcohol Drinking | 1 | 2022 | 4045 | 0.080 |
Why?
|
Case-Control Studies | 3 | 2024 | 22296 | 0.080 |
Why?
|
Blood Pressure | 1 | 2024 | 8544 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3859 | 0.080 |
Why?
|
Critical Care | 1 | 2021 | 2716 | 0.070 |
Why?
|
Plastids | 1 | 2007 | 8 | 0.070 |
Why?
|
Critical Illness | 1 | 2021 | 2754 | 0.070 |
Why?
|
Prospective Studies | 5 | 2024 | 54962 | 0.070 |
Why?
|
Ultrasonography | 1 | 2020 | 6002 | 0.070 |
Why?
|
Postprandial Period | 1 | 2009 | 320 | 0.070 |
Why?
|
Seeds | 1 | 2007 | 124 | 0.070 |
Why?
|
Pneumonia | 1 | 2018 | 2164 | 0.070 |
Why?
|
Body Mass Index | 1 | 2024 | 13055 | 0.070 |
Why?
|
Plant Oils | 1 | 2007 | 199 | 0.070 |
Why?
|
Child | 3 | 2023 | 80960 | 0.060 |
Why?
|
Pyruvate Kinase | 1 | 2007 | 190 | 0.060 |
Why?
|
Incidence | 2 | 2020 | 21547 | 0.060 |
Why?
|
Pyridines | 1 | 2016 | 2895 | 0.060 |
Why?
|
Arabidopsis | 1 | 2007 | 469 | 0.060 |
Why?
|
Sequence Analysis, RNA | 2 | 2022 | 2041 | 0.060 |
Why?
|
Genetic Loci | 2 | 2022 | 2630 | 0.050 |
Why?
|
Prevalence | 3 | 2024 | 15879 | 0.050 |
Why?
|
Myostatin | 1 | 2023 | 129 | 0.050 |
Why?
|
Logistic Models | 3 | 2022 | 13318 | 0.050 |
Why?
|
Transcription Factors | 1 | 2022 | 12174 | 0.050 |
Why?
|
Genes, Overlapping | 1 | 2021 | 36 | 0.050 |
Why?
|
Triglycerides | 1 | 2009 | 2464 | 0.050 |
Why?
|
Linear Models | 2 | 2021 | 5891 | 0.050 |
Why?
|
Biology | 1 | 2023 | 292 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 325 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2022 | 473 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5434 | 0.040 |
Why?
|
Sample Size | 1 | 2022 | 848 | 0.040 |
Why?
|
Mucin-1 | 1 | 2023 | 539 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2020 | 65480 | 0.040 |
Why?
|
Proportional Hazards Models | 2 | 2024 | 12562 | 0.040 |
Why?
|
Cardiac Output | 1 | 2020 | 838 | 0.040 |
Why?
|
Vascular Resistance | 1 | 2020 | 939 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14794 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1737 | 0.030 |
Why?
|
Europe | 1 | 2022 | 3441 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 789 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 26395 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2021 | 81903 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2018 | 13594 | 0.030 |
Why?
|
Brain Mapping | 1 | 2009 | 6739 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2016 | 969 | 0.030 |
Why?
|
Vasoconstriction | 1 | 2015 | 593 | 0.030 |
Why?
|
Monocytes | 1 | 2022 | 2603 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2748 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2022 | 59739 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1340 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2022 | 5801 | 0.020 |
Why?
|
Eosinophils | 1 | 2016 | 953 | 0.020 |
Why?
|
Sex Factors | 1 | 2024 | 10633 | 0.020 |
Why?
|
Hemodynamics | 1 | 2021 | 4199 | 0.020 |
Why?
|
Drug Design | 1 | 2015 | 1046 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2016 | 10486 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2016 | 1506 | 0.020 |
Why?
|
Survival Analysis | 1 | 2022 | 10115 | 0.020 |
Why?
|
United States | 3 | 2022 | 73186 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6291 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 40261 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4040 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7603 | 0.020 |
Why?
|
Cotyledon | 1 | 2007 | 4 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4207 | 0.020 |
Why?
|
Genes, Plant | 1 | 2007 | 129 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12095 | 0.020 |
Why?
|
Gene Expression Regulation, Plant | 1 | 2007 | 211 | 0.020 |
Why?
|
Vitamin D | 1 | 2020 | 3311 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9384 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2830 | 0.010 |
Why?
|
Hypertension | 1 | 2024 | 8617 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2007 | 1990 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2007 | 665 | 0.010 |
Why?
|
Protein Subunits | 1 | 2007 | 943 | 0.010 |
Why?
|
Carbon | 1 | 2007 | 672 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2007 | 1751 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 4413 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2024 | 39394 | 0.010 |
Why?
|
Glycolysis | 1 | 2007 | 838 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2007 | 1478 | 0.010 |
Why?
|
Animals | 3 | 2022 | 169335 | 0.010 |
Why?
|
Brain | 1 | 2009 | 27453 | 0.010 |
Why?
|
Protein Transport | 1 | 2007 | 1956 | 0.010 |
Why?
|
Dietary Fats | 1 | 2009 | 2002 | 0.010 |
Why?
|
Adolescent | 2 | 2022 | 89244 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 30046 | 0.010 |
Why?
|
Kinetics | 1 | 2007 | 6332 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2009 | 2734 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2007 | 1904 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10400 | 0.010 |
Why?
|
Quality of Life | 1 | 2020 | 13510 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6512 | 0.010 |
Why?
|
Young Adult | 1 | 2022 | 60131 | 0.010 |
Why?
|
Protein Binding | 1 | 2007 | 9344 | 0.010 |
Why?
|
Mice | 1 | 2022 | 82072 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 23653 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 9080 | 0.010 |
Why?
|
Mutation | 1 | 2007 | 30266 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 36854 | 0.000 |
Why?
|
Concepts
(191)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(107)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_